Arrhythmia-detection criteria process for a cardioverter/defibrillator

• US 5,312,443 A
• Filed: 02/20/1992
• Issued: 05/17/1994
• Est. Priority Date: 02/20/1992
• Status: Expired due to Term

• Current Assignee: Ela Medical S.A. (LivaNova Plc)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Kroll, Mark W., Adams, Theodore P., Supino, Charles G.
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): Jastrzab, Jeffrey R.
• Application Number:
  US07/837,952
• Time in Patent Office: 817 Days
• Field of Search: 128/419 D, 128/419 PG, 607/5, 607/6, 607/18, 607/19
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: Y10S 128/925 Neural network

Abstract

A major shortcoming in the prior art for detecting cardiac arrhythmias for the purpose of making an electrical intervention decision has been that each variable sensed was given in effect a "veto" over intervention on the basis of its own particular predetermined threshold value, and irrespective of the values of companion variables. The present invention overcomes this prior art problem by generating a function of relevant variables, and assigning a threshold value to the function. As a result, an individual variable can range widely for a positive intervention decision, depending upon the values of the companion variables. Thus, the intervention exploits features often described as those associated with fuzzy logic. The functions chosen for this purpose can be as one desires, with the choice depending upon the current state of advancing knowledge. Even further flexibility can be achieved by employing the principles of the neural net, wherein functional values can themselves be combined, with another threshold value assigned to the result of that combination, and so on.

Claims

1. An improved arrhythmia-detection criteria process for detecting a tachycardia/fibrillation cardiac arrhythmia in a human patient by a cardioverter defibrillator device connected to at least two implanted electrodes located in the human patient that can selectively deliver cardioversion/defibrillation cardiac arrhythmia-correcting electrical intervention therapy comprised of one or more electrical pulses of greater than about 0.1 Joules, the process including the device-implemented steps of:

(a) continually receiving a plurality of cardiac variables representing sensed values in the human patient, (b) evaluating the plurality of cardiac variables to determine whether a tachycardia/ fibrillation cardiac arrhythmia is present, and (c) if such an arrhythmia is present, determining an appropriate therapy to be delivered to treat the arrhythmia, the improvement comprising the device-implemented sub-steps of follows;

(b1) using one or more chosen mathematical algebraic functions relating two or more of the cardiac variables to generate a threshold criterion that is at least a threshold curve; and

(b2) using the threshold curve to define a boundary above which a tachycardia/fibrillation cardiac arrhythmia is deemed to be present.

2. The process of claim 1 wherein the chosen function is the product of at least two cardiac variables.

3. The process of claim 1 wherein the chosen function is a product of at least two cardiac variables with a weight in the form of an exponent of a power associated with each variable.

4. The process of claim 1 wherein the chosen function is the sum of at least two cardiac variables.

5. The process of claim 1 wherein the chosen function is the sum of at least two cardiac variables with a weight in the form of a multiplicative factor associated with each variable.

6. The process of claim 1 wherein the chosen function is the sum of at least two cardiac variables with a weight in the form of an exponent of a power associated with each variable.

7. The process of claim 1 wherein the chosen function is the sum of at least two cardiac variables with weights in the form of a multiplicative factor associated with each variable and additional weights in the form of exponents of a power associated with each variable.

8. The process of claim 1 wherein the cardiac variables employed include at least one of these variables:

rate, onset, duration, correlations, absolute-amplitude ratio, stability, and the physiological-variables blood pressure and blood pH.

9. The process of claim 1 wherein two or more mathematical algebraic functions are used in step (b1) and neural-net principles are used to generate at least one of the two or more mathematical algebraic functions.

10. An improved arrhythmia-detection criteria process for detecting a tachycardia/fibrillation cardiac arrhythmia in a human patient by a cardioverter defibrillator device connected to at least two implanted electrodes located in the human patient that can selectively deliver cardioversion/defibrillation cardiac arrhythmia-correcting electrical intervention therapy comprised of one or more electrical pulses of greater than about 0.1 Joules, the process including the device-implemented steps of:

(a) continually receiving a plurality of cardiac variables representing sensed values in the human patient, (b) evaluating the plurality of cardiac variables to determine whether a tachycardia/fibrillation cardiac arrhythmia is present, and (c) if such an arrhythmia is present, determining an appropriate therapy to be delivered to treat the arrhythmia, the improvement comprising the device-implemented sub-steps as follows;

(b1) selecting an explicit and well-defined threshold intervention criteria which is at least a threshold curve defined by one or more mathematical algebraic functions relating two or more of the cardiac variables;

(b2) using the threshold curve to define a boundary above which a tachycardia/fibrillation cardiac arrhythmia is deemed to be present by permitting individual cardiac variables to vary within wide limits at threshold conditions, depending upon the values of companion variables.

11. An improved arrhythmia-detection criteria process for detecting a tachycardia/fibrillation cardiac arrhythmia in a human patient by a cardioverter defibrillator device connected to at least two implanted electrodes located in the human patient that can selectively deliver cardioversion/defibrillation cardiac arrhythmia-correcting electrical intervention therapy comprised of one or more electrical pulses of greater than about 0.1 Joules, the process including the device-implemented steps of:

(a) continually receiving a plurality of cardiac variables representing sensed values in the human patient, (b) evaluating the plurality of cardiac variables to determine whether a tachycardia/fibrillation cardiac arrhythmia is present, and (c) if such an arrhythmia is present, determining an appropriate therapy to be delivered to treat the arrhythmia, the improvement comprising the device-implemented sub-steps as follows;

(b1) using two or more functions, each function relating two or more of the cardiac variables, to generate a threshold criterion; and

(b2) combining the threshold criterion generated in step (b1) by using a mathematical algebraic function that relates the threshold criterion in terms of inputs to a neural-network, an output of which defines a boundary above which a tachycardia/fibrillation cardiac arrhythmia is deemed to be present.

12. The process of claim 11 wherein one or more of the functions of step (b1) are mathematical algebraic functions.

13. The process of claim 11 wherein one or more of the functions of step (b1) are implemented as a neural-network.

14. The process of claim 11 wherein the neural-network is implemented in software in a processor within the device.

15. The process of claim 11 wherein the neural-network is implemented in hardware circuitry within the device.

16. An improved arrhythmia-detection criteria process for detecting a tachycardia/fibrillation cardiac arrhythmia in a human patient by a cardioverter defibrillator device connected to at least two implanted electrodes located in the human patient that can selectively delivery cardioversion/defibrillation cardiac arrhythmia-correcting electrical intervention therapy comprised of one or more electrical pulses of greater than about 0.1 Joules, the process including the device-implemented steps of:

(a) continually receiving a plurality of cardiac variables representing senses values in the human patient, (b) evaluating the plurality of cardiac variables to determine whether a tachycardia/fibrillation cardiac arrhythmia is present, and (c) if such an arrhythmia is present, determining an appropriate therapy to be delivered to treat the arrhythmia, the improvement comprising the device-implemented sub-steps as follows;

(b1) using one or more mathematical algebraic functions, each function relating two or more of the cardiac variables and being implemented as a neural network, to generate at least a threshold curve; and

(b2) using the threshold curve to define a boundary above which a tachycardia/fibrillation cardiac arrhythmia is deemed to be present.

17. The process of claim 16 wherein at least one neural-network is implemented in software in a processor within the device.

18. The process of claim 16 wherein at least one neural-network is implemented in hardware circuitry within the device.